여성 저활동성 성욕 장애 치료제 시장 점유율 분석 및 기회 [2025-2031]
Female Hypoactive Sexual Desire Disorder Therapeutics Market Report Analysis
Female Hypoactive Sexual Desire Disorder Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Allergan plc
- AMAG Pharmaceuticals, Inc.
- Emotional Brain BV
- Endoceutics, Inc.
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Palatin Technologies Inc
- Pivot Pharmaceuticals Inc
- Sprout Pharmaceuticals, Inc.
Regional Overview
- 북미
- 유럽
- 아시아 태평양
- 중남미
- 중동 및 아프리카
Market Segmentation
By 치료
- 테스토스테론
- 플리반세린
- 부스피론
- 부프로피온
- 브레멜라노타이드
- 인지 행동 치료
By 신청
- 입원환자
- 외래환자
By 지리
- 북미
- 유럽
- 아시아 태평양
- 중남미
Get Free Sample For